Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities.
about
Gold nanoprobes for theranosticsRecent advances of biomaterials in biotherapyStrategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer TherapeuticsBioreducible liposomes for gene delivery: from the formulation to the mechanism of actionAntibody drug conjugates: design and selection of linker, payload and conjugation chemistrySmart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Extracellularly activatable nanocarriers for drug delivery to tumors.Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cellsStimuli-Responsive Materials for Controlled Release of Theranostic Agents.Multifunctional polymeric micelles for delivery of drugs and siRNA.Polymer-coated echogenic lipid nanoparticles with dual release triggers.A cell nanoinjector based on carbon nanotubes.Mechanochemical delivery and dynamic tracking of fluorescent quantum dots in the cytoplasm and nucleus of living cellsPluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity.Smart Microparticles with a pH-responsive Macropore for Targeted Oral Drug Delivery.Green polymer chemistry: investigating the mechanism of radical ring-opening redox polymerization (R3P) of 3,6-dioxa-1,8-octanedithiol (DODT).Cell-Penetrating, Guanidinium-Rich Oligophosphoesters: Effective and Versatile Molecular Transporters for Drug and Probe Delivery.DNA release dynamics from reducible polyplexes by atomic force microscopy.Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance.Polymeric micelles with ionic cores containing biodegradable cross-links for delivery of chemotherapeutic agents.Short biodegradable polyamines for gene delivery and transfection of brain capillary endothelial cellsProtein disulphide isomerase-assisted functionalization of keratin-based matrices.Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.Gold nanoparticles: preparation, properties, and applications in bionanotechnologyFunctionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery.Cell-penetrating, guanidinium-rich molecular transporters for overcoming efflux-mediated multidrug resistance.Bioreducible polymers for therapeutic gene deliveryPRINT: a novel platform toward shape and size specific nanoparticle theranostics.Targeted delivery of antigen processing inhibitors to antigen presenting cells via mannose receptors.Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel.Biocleavable Polycationic Micelles as Highly Efficient Gene Delivery Vectors.Self-assembling mini cell-penetrating peptides enter by both direct translocation and glycosaminoglycan-dependent endocytosis.Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjectsUnlocking a caged lysosomal protein from a polymeric nanogel with a pH trigger.Design and characterization of novel recombinant listeriolysin O-protamine fusion proteins for enhanced gene delivery.Inorganic-organic hybrid nanomaterials for therapeutic and diagnostic imaging applications.Experimental and theoretical investigations in stimuli responsive dendrimer-based assemblies.Application of a water-soluble pyridyl disulfide amine linker for use in Cu-free click bioconjugation.Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells.
P2860
Q24629197-13B2D477-3C4F-449C-ADB2-F80F49630C0CQ26752054-8DE0766A-C9A3-45E5-82DB-10A181178C67Q26780335-4BB2B042-E710-4F4F-B43F-6050F3DF7D5DQ28475808-50E8CD13-0E4F-4EFA-8808-E058EF84721AQ28544658-D5496960-20C0-45AB-8D3E-E7AEECA14AC0Q30361646-DD104E88-7D4C-4DCC-8148-92FAB8D20517Q30366990-C1248CA8-6B21-44AE-8B08-34BB6C128FC2Q30401826-D1CEE9E4-09A8-4503-BA7B-2336E4F35C87Q30405605-14491CB7-EE36-41A1-9869-2F62D83BC291Q30406730-D846B4B8-ED33-4A34-8E25-B8878B548D8DQ30438973-A786BF0B-7C62-4A9A-BEF6-BD32EF830364Q30441883-2A4FAA89-73DC-457F-8298-844445EAE460Q30479653-AF20A7C9-13B8-4A97-9BFC-2609D9A6DAA2Q30488812-30F027DE-6290-4206-A217-914399B40F3DQ30592302-DC1B8D42-6927-4731-9AE1-B7D10E4889EAQ30855198-56144F6C-FC25-4F5D-8CFA-1044ABFDF5B3Q30931196-D614650C-FCC4-4B97-886D-C97365743096Q31048147-21CC97A2-5768-41DE-BAB9-F6DB5729401EQ33671439-C0BC4EEA-6EE7-4852-8DBF-F2B4A41401EAQ33693048-EBAEB348-DF33-4570-B534-2141EB0FE073Q33787790-7A9D5CD5-1728-442E-BAEB-F323BEF7062AQ33811724-CCA1F61B-8750-4CAD-9F99-71535837DF0DQ33851893-AF71A327-9249-446F-B650-D7B8CC26CBDEQ33902253-98DEA243-0C73-4101-93F3-9EBB65BE2C21Q33914355-315084D7-4BD0-45BD-9F49-7593906A2774Q33925595-C7E6FF20-FE66-4AD1-BD66-EC042841BE3CQ34011165-C30ED000-B56C-4DEE-B341-B09884BF3E14Q34079568-092A0C80-68E4-4CE3-B02C-E69D7490F650Q34149121-0440AB70-9DCF-4D46-97A9-9601551F74B3Q34178749-E9573BB1-893F-4ADE-A1E1-AEC718F7AA31Q34197017-DED1D616-1078-4BB6-B773-FAFC0273A824Q34242870-7273B2BF-F6E1-42C4-8CEE-93B6975D9C66Q34301639-A17E789E-9462-4883-96FD-87986A4CDFCBQ34385273-F57240DB-3C12-4795-B058-011BAC30403CQ34496997-053EDB55-376E-4F39-9803-D3B959984AFEQ35057551-C1195562-8DEF-47AF-8D65-0A294220F94BQ35091821-C3AFEB01-C68B-4106-92E7-41D4B6B634D8Q35107030-F55B84B3-DA3C-4178-A75B-314633E0EC2AQ35148819-BF8DE119-F321-4AF5-90E8-D7707AD572EDQ35162222-D62737FA-F05D-4C3A-91D0-D0AF33945EF7
P2860
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Drug delivery strategy utilizi ...... cellular reducing activities.
@ast
Drug delivery strategy utilizi ...... cellular reducing activities.
@en
type
label
Drug delivery strategy utilizi ...... cellular reducing activities.
@ast
Drug delivery strategy utilizi ...... cellular reducing activities.
@en
prefLabel
Drug delivery strategy utilizi ...... cellular reducing activities.
@ast
Drug delivery strategy utilizi ...... cellular reducing activities.
@en
P2093
P1476
Drug delivery strategy utilizi ...... cellular reducing activities.
@en
P2093
Joel A Swanson
Kyung-Dall Lee
P304
P356
10.1016/S0169-409X(02)00179-5
P407
P577
2003-02-01T00:00:00Z